Sedation with oral benzodiazepines in dental practice in cardiac patients by Santos, Monah Sampaio et al.
Clin Lab Res Den 2019: 1-8 ●  1
Special Care
linical  and Laboratorial  
Research in Dentistry
in
1
Sedation with oral benzodiazepines in dental 
practice in cardiac patients: a literature review
• Monah Sampaio Santos Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Dental Unit, São 
Paulo,  Brazil  • Wladimir Gushiken Campos Department  of  Oral Medicine,  Faculdade  de Odontologia,  Universidade  de  São 
Paulo, São Paulo, Brazil  • Camilla Vieira Esteves Department of Oral Medicine, Faculdade de Odontologia, Universidade de 
São Paulo, São Paulo, Brazil  • Marcela Alves dos Santos-Paul Heart Institute (InCor) do Hospital das Clínicas da Faculdade 
de Medicina da Universidade de São Paulo, Dental Unit, São Paulo, Brazil  • Cíntia Maria Alencar de Carvalho Heart Institute 
(InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Dental Unit, São Paulo, Brazil  • Tania 
Cristina Pedroso Montano Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São 
Paulo, Dental Unit, São Paulo, Brazil  • Itamara Lucia Itagiba Neves Heart Institute (InCor) do Hospital das Clínicas da Faculdade 
de Medicina da Universidade de São Paulo, Dental Unit, São Paulo, Brazil  • Ricardo Simões Neves Heart Institute (InCor) do 
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Dental Unit, São Paulo, Brazil  • Celso Augusto 
Lemos Department of Oral Medicine, Faculdade de Odontologia, Universidade de São Paulo, São Paulo, Brazil
 ABSTRACT |	 There	are	different	types	of	sedation	used	for	performing	medical	and	dental	procedures.	The	medications	most	com-
monly	used	for	this	purpose	are	benzodiazepines,	which	are	considered	safe	and	effective	in	the	hospital	or	outpatient	
dental	practice.	However,	in	dental	clinical	practice,	they	are	underutilized,	especially	in	patients	with	cardiovascular	
disease.		The	aim	of	this	study	was	to	address	the	use	of	benzodiazepines	as	oral	sedatives,	their	indications,	contrain-
dications,	and	peculiarities,	as	well	as	their	correlation	with	cardiac	patients,	through	a	literature	review.	Sedation	or	
minimum	anxiolysis	is	a	drug-induced	state	during	which	patients	respond	normally	to	verbal	commands	and	airway	
reflexes,	while	respiratory	and	cardiovascular	functions	are	unaffected.	The	beneficial	effects	of	benzodiazepines	inclu-
de	reduced	anxiety,	sleep	induction	and	maintenance,	muscle	relaxation,	and	treatment	and	prevention	of	epileptic	sei-
zures.	Benzodiazepines	are	indicated	for	patients	with	anxiety	but	should	be	used	with	caution	in	patients	with	serious	
illnesses,	pregnancy	or	using	other	central	nervous	system	depressants.	Its	use	in	cardiac	patients	is	safe	and	effective	
because	it	reduces	the	hemodynamic	function.	It	is	important	for	the	dentist	to	know	and	use	this	class	of	medications,	
improving	the	quality	of	care	for	the	cardiac	patient.
 KEYWORDS |	 Benzodiazepines;	Heart	Disease;	Dentistry.
 RESUMO | Sedação com benzodiazepínicos orais na prática odontológica em pacientes cardíacos: uma revisão de literatura •	Existem	
diferentes	tipos	de	sedação	utilizados	para	a	realização	de	procedimentos	médicos	e	odontológicos.	As	medicações	mais	comumente	
usadas	para	este	fim	são	os	benzodiazepínicos,	considerados	seguros	e	efetivos	na	prática	odontológica	hospitalar	ou	ambulatorial.	No	
entanto,	na	prática	clínica	odontológica,	eles	são	subutilizados,	especialmente	em	pacientes	com	doenças	cardiovasculares.	O	objetivo	
deste	estudo	 foi	 abordar	o	uso	de	benzodiazepínicos	 como	sedativos	orais,	 suas	 indicações,	 contraindicações	e	peculiaridades,	bem	
como	sua	correlação	com	pacientes	cardíacos,	através	de	uma	revisão	da	literatura.	Sedação,	ou	ansiólise	mínima,	é	um	estado	induzido	
por	medicamentos,	durante	o	qual	os	pacientes	respondem	normalmente	a	comandos	verbais	e	 reflexos	das	vias	aéreas,	enquanto	a	
função	respiratória	e	cardiovascular	não	é	afetada.	Os	efeitos	benéficos	de	benzodiazepínicos	incluem	redução	da	ansiedade,	indução	e	
manutenção	do	sono,	relaxamento	muscular	e	tratamento	e	prevenção	de	convulsões	epiléticas.	Benzodiazepínicos	são	indicados	para	
pacientes	com	ansiedade,	mas	devem	ser	usados	com	cautela	em	pacientes	com	doenças	graves,	gravidez	ou	que	utilizem	outros	depres-
sores	do	sistema	nervoso	central.	É	importante	que	o	dentista	conheça	e	use	esta	classe	de	medicamentos,	melhorando	a	qualidade	de	
atendimento	para	o	paciente	cardíaco.
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INTRODUCTION 
There	are	different	types	of	sedation	used	for	
conducting	medical	and	dental	procedures.	Each	
type	of	sedation	will	lead	to	a	patient’s	response,	
who	must	be	aware	of	the	entire	process,	and,	to	be	
performed,	it	requires	professionals	with	specific	
techniques	and	skills.	The	type	of	sedation	should	
be	appropriate	for	each	patient	and	each	procedure	
to	be	performed.1
It	is	already	well	established	in	literature	that	
anxiety,	discomfort	and	pain	can	be	reduced	during	
dental	procedures,	and	the	use	of	conscious	sedation	
requires	dosages	that	allow	verbal	communication	
during	procedures.	The	most	 commonly	used	
medications	for	this	purpose	are	benzodiazepines,	
considered	safe	and	effective	in	the	hospital	or	
outpatient	dental	practice.2,3
It	is	important	to	note	that	surgical	procedures	
involving	a	high	level	of	emotional	stress	release	
endogenous	 catecholamines	 in	 response	 to	
neurohumoral	stimulation	and,	when	combined	with	
the	use	of	local	anaesthetics	with	a	sympathomimetic	
vasoconstrictor,	might	 cause	 changes	 in	 the	
cardiovascular	system.	This	poses	risks	that	can	be	
greater	than	those	expected	in	conscious	sedation,	
especially	for	those	with	systemic	diseases.4
However,	 few	 dentists	 use	 these	 drugs	 in	
clinical	practice,	perhaps	for	lack	of	knowledge	on	
the	benefits	of	these	medicines	or	by	uncertainty	
regarding	the	side	effects	of	the	treatment,	especially	
in	patients	with	cardiovascular	disease.
Therefore,	the	aim	of	this	study	was	to	address	
the	use	of	benzodiazepines	as	oral	sedatives,	their	
indications,	contraindications,	and	peculiarities,	as	
well	as	their	correlations	with	cardiac	patients.
MATERIALS AND METHODS 
This	literature	review	was	conducted	in	the	
PubMed	database,	regardless	of	the	year,	using	the	
following	descriptors:	(benzodiazepine	oral)	OR	(oral	
sedative	premedication	AND	cardiac	patients)	OR	
(oral	benzodiazepines	AND	cardiology)	OR	(oral	
benzodiazepines	AND	heart	disease).
LITERATURE REVIEW 
Benzodiazepines 
According	to	the	Academy	of	Medical	Royal	
Colleges,	 there	are	 several	 levels	of	 sedation.	
Sedation	is	an	individual	state	of	depression	of	
consciousness,	with	 	dose-response	dependent	
on	the	drugs	used,	which	can	result	 in	 loss	of	
consciousness.	In	light	sedation,	or	anxiolysis,	verbal	
responses	are	maintained;	there	is	no	change	in	the	
airway,	breathing	and	cardiovascular	function.	In	
moderate	sedation,	commonly	known	as	conscious	
sedation,	there	is	a	response	to	verbal	and	tactile	
stimulation,	respiratory	assistance	and	adequate	
ventilation	are	not	required,		cardiovascular	function	
is	generally	maintained,	and	it	is	considered	safe.	In	
deep	sedation,	there	is	no	response	to	stimuli,	it	is	
necessary	to	intervene	in	breathing	and	ventilation,	
while	cardiovascular	function	is	usually	maintained.5
The	American	Society	of	Anesthesiologists	
defines	minimal	sedation,	or	anxiolysis,	as	“a	
drug-induced	state	during	which	patients	respond	
normally	to	verbal	commands.	Although	cognitive	
function	and	physical	coordination	may	be	impaired,	
airway	reflexes,	and	ventilatory	and	cardiovascular	
functions	are	unaffected.”6
Surgical	procedures	can	lead	to	a	high	level	of	
anxiety,	especially	in	children,	which	may	cause	
significant	medical,	 psychological	 and	 social	
consequences.	One	way	to	alleviate	this	suffering	
preoperatively	may	be	administering	sedatives	
that	will	thus	facilitate	the	time	of	anesthesia.	The	
effects	of	sedative	medications	might	be:	amnesia,	
anxiolysis,	decreased	psychological	stress	and	
reduced	need	for	general	anesthesia.7,8
In	the	late	1970s,	benzodiazepines	have	become	
commonly	prescribed	drugs	worldwide.	Due	to	their	
sedative	effect	combined	with	low	toxicity,	they	were	
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considered	the	ideal	conditions	for	many	common	
medicines.9
In	Brazil,	 stress	and	pain	control	 in	dental	
practice	is	not	routine,	probably	due	to	the	lack	of	
attention	given	to	this	issue	during	the	training	of	
the	dentist,	even	regarding	the	most	known	forms	
of	sedation,	such	as	the	oral	use	of	benzodiazepines.	
Anxiety	concerning	dental	treatment	is	still	very	
common,	a	factor	that	often	prevents	adherence	to	
the	treatment.10,11
Sedative	medication	 has	 great	 benefits	 in	
children,	adolescents,	patients	with	negative	past	
history	associated	with	hospitalization	and	patients	
with	limited	cooperation	and	communication.7
According	to	Baldwin	et	al.	(2013),	the	beneficial	
effects	of	benzodiazepines	include	reduced	anxiety,	
induction	 and	maintenance	 of	 sleep,	muscle	
relaxation,	 and	 treatment	 and	 prevention	 of	
epileptic	seizures.	These	are	properties	of	various	
benzodiazepines	in	different	degrees,	which	will	
depend	on	their	potency,	pharmacokinetic	properties	
and	their	connection	with	the	receptors	of	the	
gamma-aminobutyric	acid	(GABA).12
Benzodiazepines	specifically	activate	the	inhibitory	
neurotransmitter	GABAA	receptor	chloride,	increasing	
GABA	activity	and	neuronal	depression	by	reducing	
the	metabolism	and	cerebral	blood	flow.13
According	to	scientific	literature,	respiratory	
depression	is	an	adverse	effect	of	benzodiazepines	
and,	therefore,	caution	should	be	taken	if	the	patient	
has	chronic	respiratory	failure.14
They	should	also	be	used	with	caution	in	patients	
who	are	treated	with	other	central	nervous	system	
depressants,	patients	with	kidney	or	liver	disease,	
severe	congestive	heart	failure,	in	pregnancy	and	
during	lactation.10	In	these	cases,	in	order	to	perform	
sedation	safely,	some	parameters	must	be	followed:15
• Perform	previous	assessments	and	associated	
comorbidities;
• Assure	that	the	patient	is	fasting;
• Assess	the	duration	of	the	procedure;
• Knowledge	on	the	importance	of	pharmacology	
of	drugs	used	and	antagonists;
• Conduct	monitoring	and	recovery	of	the	pa-
tient;
• Have	onsite	support	necessary	for	emergency	
airway	rescue	manouvres,	if	necessary.
Among	the	unwanted	effects	of	benzodiazepines	
are	 delirium,	 disorientation,	 hallucinations,	
disinhibition,	aggression,	tolerance,	and	dependency,	
if	used	 continually	 and	 indiscriminately.	The	
paradoxical	effects	are	more	common	in	children	
and	in	the	elderly,	with	low	incidence	when	used	in	
a	single	dose.2,9,10,12
Small	doses	of	benzodiazepine	anxiolytics	have	a	
little	clinically	significant	effect	on	cardiorespiratory	
function,	but	high	parenteral	dosage	may	cause	
loss	of	upper	airway	muscle	 tonus,	decreased	
ventilatory	 response,	and	decreased	systemic	
vascular	resistance,	thus	requiring	a	higher	level	of	
monitoring.13
Furthermore,	one	of	the	great	advantages	of	using	
conscious	sedation	is	the	reduced	anxiety	and	patient	
discomfort,	which	decreases	the	risks	that	might	be	
caused	by	general	anaesthesia.16
Another	 great	 advantage	 is	 the	 presence	
of	 a	 benzodiazepine	 antagonist	 drug	 that	
reverses	the	sedative,	hypnotic,	and	respiratory	
suppressive	effects,	 f lumazenil.	Flumazenil	 is	
an	 imidazobenzodiazepine	 that	 competitively	
antagonizes	 the	same	receptor;	 it	can	be	used	
intravenously	or	intranasally.	Reversal	effects	are	
noticeable	within	1-2	min	and	peak	in	6-10	min.	The	
duration	of	flumazenil’s	effect	is	30-60	min,	with	an	
elimination	half-life	shorter	than	Midazolam.2
Diazepam 
Diazepam	 is	 a	 long-acting	benzodiazepine	
often	used	for	sedation,	amnesia	induction,	or	
pre-procedure.	It	is	rapidly	absorbed	after	oral	
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administration.	Despite	a	long	half-life	of	30	to	
60	hours,	 the	clinical	 term	sedation	after	oral	
administration	is	much	shorter	than	expected,	
due	to	its	rapidly	changing	distribution	outside	the	
central	nervous	system.	The	elimination	half-life	
and	systemic	availability	of	benzodiazepines	also	
vary	significantly	with	the	age,	sex,	and	weight	of	
the	patient.17
Its	onset	of	action	occurs	in	about	60	minutes;	
however,	it	is	not	used	for	short	dental	procedures	
because	its	effect	can	last	12-24	hours.	The	usual	
dosage	is	5-10mg	for	adults,	5mg	for	older	people,	
and	0.2-05mg	/	kg	for	children.10
Although	pharmacokinetic	studies	suggest	that	
Midazolam	would	be	preferable	than	Diazepam,	in	
a	randomized	sedation	for	cardioversion	comparing	
Diazepam	 and	Midazolam,	 the	 effectiveness	
of	sedation	and	amnesia	was	the	same,	but	the	
normalization	of	the	mental	test	score	was	much	
faster	with	Diazepam.	This	early	wakefulness	may	
have	advantages	for	monitoring	recovering	patients	
after	the	procedure.1	Both	drugs	are	in	the	list	of	
essential	medicines	recommended	for	the	health	of	
the	majority	of	the	population.18
In	a	study	by	Ashraf	et	al.	(2015),	in	a	sample	of	
93	elderly	and	cardiac	patients	who	would	undergo	
a	catheterization	procedure,	47	patients	were	oraly	
premedicated	with	diphenhydramine	25	mg	and	
Diazepam	5	mg	,	while	the	others	did	not	receive	
medication.	The	author	noted	that	none	of	the	
patients	in	both	groups	developed	delirium.	The	
cooperation	of	the	patient,	the	ease	of	the	procedure	
and	reduced	need	for	medication	before	and	during	
the	procedure	were	higher	in	pre-medicated	group.19
Midazolam 
Midazolam	has	a	faster	onset	of	action	following	
oral	administration	of	approximately	30	minutes,	
and	a	short	duration	of	action	with	an	elimination	
half-life	of		approximately	2	hours	(1-4	hours).	This	
pharmacokinetic	profile	makes	oral	Midazolam	
an	adequate	preoperative	medication	for	minor	
surgeries.10,20	 It	also	has	a	known	anterograde	
amnesic	effect.21	Due	to	these	properties,	it	is	the	
most	 commonly	used	 sedating	medication	 in	
children.7
Midazolam	can	be	administered	intravenously,	
intramuscularly,	intranasally,	rectally	and	orally	
with	varying	doses	and	respective	action.2	The	usual	
dose	for	adults	is	7.5-15	mg,	7.5	mg	for	the	elderly	and	
0.25-0.5	mg/kg	for	children.10
Abdul-Latif	et	al.	(2001)	conducted	a	placebo-
controlled,	randomized,	double-blind	prospective	
study	to	evaluate	the	pre-anaesthetic	efficacy	of	
oral	Midazolam	7.5	mg	in	50	ASA	I	and	II	patients	
scheduled	for	breast	surgery.	The	results	of	the	
study	 indicated	a	small	decrease	 in	heart	rate	
and	systolic	blood	pressure,	and	the	induction	of	
general	anesthesia	was	obtained	with	a	lower	dose	
of	propofol.20
In	a	comparative,	prospective,	randomized,	and	
double-blind	study	performed	by	Middlehurst	et	
al.	(1999),	50	ASA	III	and	IV	cardiac	patients	with	
dental	problems	were	divided	into	two	groups.	Group	
1	used	anaesthesia	with	2%	lidocaine,	epinephrine	
1:	 50,000	 and	 vasopressin	 0,25UI	 /	 ml	 for	
performing	dental	procedures,	while	Group	2	used	
the	same	anaesthesia	associated	with	sedation	with	
intravenous	Midazolam.	There	was	no	difference	
between	groups.	The	authors	stress	that	Midazolam	
should	be	given	as	a	protocol	in	performing	dental	
procedures	in	cardiac	patients.22
Shibuya	et	al.	(2003)	conducted	a	retrospective	
study	 of	 25	 patients	 with	 hypertrophic	 and	
dilated	 cardiomyopathy,	 in	 which	 the	 heart	
function	was	assessed	by	echocardiography	and	
electrocardiography	during	the	dental	procedure.	
The	patients	were	divided	into	3	distinct	groups.	In	
the	first	group,	invasive	procedures	were	performed	
under	local	anaesthesia;	in	the	second	group,	non-
invasive	procedures	were	conducted	under	local	
anaesthesia;	and	in	the	third	one,	non-invasive	
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procedures	were	performed	without	anaesthesia.	
Sedation	was	performed	with	Midazolam,	Diazepam	
and	Flunitrazepam	in	intravenous	doses.	A	total	
of	87	dental	treatment	sessions	were	held,	and	it	
was	observed	that	40%	of	patients	reported	dental	
fear.	The	authors	found	no	relation	between	the	
types	of	anaesthetic,	and	sedation	did	not	influence	
the	 cardiovascular	 alterations	 found	 on	 the	
electrocardiogram.23
The	control	and	prevention	of	adverse	effects	of	
benzodiazepine	agents	on	the	central	nervous	and	
cardiovascular	systems,	such	as	anxiolytics,	were	
reported	by	several	authors,	and	Midazolam	is		the	
drug	of	choice	since	it	has	faster	effects	and	shorter	
duration	than	other	medications.4
Studer	 et	 al.	 (2012)	 evaluated	 the	 use	 of	
Clonidine	150	mg	compared	to	Midazolam	7.5	mg	
for	premedication	in	surgical	extraction	of	the	third	
molar.	It	was	a	prospective,	randomized,	crossover,	
double-blind	study,	in	which	10	patients	undergoing	
bilateral	dental	extraction	received	Clonidine	or	
Midazolam	orally	1	h	before	treatment.	Patients	who	
received	Midazolam	for	the	first	surgery	received	
Clonidine	in	the	second	operation	and	vice	versa.	
There	was	no	significant	difference	between	both	
drugs,	and	patient	satisfaction	did	not	differ	between	
groups.24
Alprazolam 
A lprazolam, 	 when	 compared	 to 	 other	
benzodiazepines,	has	the	highest	anxiolytic	activity,	
with	an	onset	of	1.4	hour	and	an	elimination	half-life	of	
10.6	hours.	Its	main	effects	are	the	reduction	of	anxiety	
and	panic	attacks	in	patients,	thus	being	a	possible	
alternative	premedication	for	surgical	patients.25
Alprazolam	 is	 an	 anxiolytic	 agent	used	 as	
pre-medication	due	to	its	short	half-life,	rapid	
effect	and	ease	of	use	when	compared	to	other	
benzodiazepines.26
Its	effect	lasts	for	about	1-2	hours	and	it	has	a	
lower	incidence	of	paradoxical	effects	or	anterograde	
amnesia,	being	a	good	alternative	to	sedation.	Its	
usual	dose	is	0.5-0.75	mg	for	adults,	0.25-0.5	for	
the	elderly,	and,	for	children,	Alprazolam	is	not	
indicated.10
As	oral	premedication,	Alprazolam	0.5	mg	
decreased	 anxiety	 in	 the	 same	proportion	 as	
Midazolam	0.75	mg.	In	80%	of	patients,	Alprazolam	
was	as	effective	as	Midazolam	to	reduce	anxiety,	but	
their	amnesic	effects	were	not.10
A	study	by	Kim	et	al. 25	compared	the	use	of	pre-
surgery	sedation	in	58	patients;	Alprazolam	0.5	mg	
showed	a	lower	incidence	of	amnesia	in	comparison	
with	Triazolam	0.25	mg	in	the	study	sample.	No	
cases	of	respiratory	depression,	emergencies	or	other	
effects	were	reported.
Cubuk	et	al.	(2011)	evaluated	the	heart	rate	
variability	during	coronary	angiography	procedure	
and	concluded	that	Alprazolam	reduces	anxiety,	
decreases	heart	rate	variability	and	improves	the	
quality	of	imaging.26
Triazolam 
Triazolam	is	premedication	used	for	anxious	
patients	or	patients	with	severe	insomnia.	Despite	
its	potential	hypnotic,	amnesic,	anxiolytic,	sedative,	
anticonvulsant	and	muscle	relaxant	effects,	 it	
is	generally	not	indicated	as	a	premedication	by	
anesthesiologists	because	of	its	persistent	effects.	
Compared	with	other	benzodiazepines,	Triazolam	
has	a	rapid	onset	and	short	duration	of	action.	It	is	
able	to	induce	a	state	of	drowsiness	with	minimal	
effects	on	respiration	and	myocardium.	The	peak	
effect	is	reached	in	approximately	1	hour,	and	its	
effects	are	sedation,	amnesia	and	reduced	anxiety.25
Due	to	its	potential	to	anterograde	amnesia,	the	
faster	onset	of	action	and	a	shorter	plasma	half-
life,	from	1.5	to	5.5	hours,	Triazolam	was	chosen	
in	a	 study	by	Fabian	et	al.	 (2006)	as	 sedative	
administrated	orally	prior	cardioversion	in	patients	
with	atrial	fibrillation.	Cardioversion	is	a	method	to	
restore	normal	sinus	rhythm,	but	the	disadvantage	
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is	that	the	delivered	cardioversion	shocks	are	usually	
carried	out	without	anaesthesia	or	sedation,	causing	
a	painful	experience	for	patients.	Previous	use	of	
Triazolam	decreased	anxiety,	discomfort,	pain	
and	caused	amnesia	in	some	patients	compared	to	
placebo.27
The	usual	doses	used	orally	are	0.125-0.25	mg	
for	adults,		0.06-0.125	mg	for	the	elderly,	and,	for	
children,	it	is	not	recommended;	this	medication	
would	be	ideal	for	use	in	the	elderly	due	to	its	rapid	
onset	and	short	duration	of	action,	but	it	is	not	
commercially	available	in	Brazil.	10
Lorazepam 
Lorazepam	 is	 the	 ideal	 drug	 for	 sedation	
of	geriatric	patients;	 its	plasma	half-life	 is	an	
intermediate	between	Triazolam	and	Diazepam,	
and	it	has	a	lower	incidence	of	paradoxical	effects.	
The	time	required	for	the	onset	of	drug	effect	is	1-2	
hours,	the	plasma	half-life	is	12-20	hours	and	the	
duration	of	effects	is	2-3	hours.	In	older	adults,	the	
usual	dose	is	1	mg,	and	1-2	mg	for	adults;	it	is	not	
suitable	for	children.10
Saccomarmo	et	al.	28	compared	the	effects	of	
Lorazepam	alone	 and	Lorazepam,	morphine,	
and	perphenazine	on	cardiorespiratory	variables,	
sedation,	and	anxiety	in	patients	scheduled	for	
coronary	artery	bypass	graft.	The	authors	concluded	
that	Lorazepam	alone	can	be	used	safely	as	a	
premedication	in	patients	with	critical	coronary	
artery	stenosis.
DISCUSSION 
Medications	such	as	anxiolytics	are	not	widely	
used	for	minor	surgery	due	to	possible	complications	
in	the	postoperative	period,	besides	causing	delayed	
recovery	from	anaesthesia	and	patient	discharge.20
However,	oral	benzodiazepines	are	an	effective	
and	safe	alternative	 to	control	anxiety	during	
dental	treatment.	The	use	of	Benzodiazepines	is	
indicated	to	reduce	anxiety,	induce	and	maintain	
sleep,	muscle	relaxation,	and	to	treat	and	prevent	
seizures.	They	are	contraindicated	for	patients	with	
chronic	respiratory	failure	or	who	use	other	drugs	
or	substances	that	cause	central	nervous	system	
depression.3,7,12,14
In	scientific	literature,	there	is	a	predominant	use	
of	Midazolam	due	to	the	effects	of	rapid	onset	and	
shorter	duration	than	others;	however,	Diazepam	has	
the	same	effectiveness	in	sedation.	Alprazolam	and	
Triazolam,	in	addition	to	their	anxiolytic	properties,	
have	great	potential	for	amnesia.	Lorazepam	is	the	
medication	of	choice	for	the	elderly	due	to	lower	
prevalence	of	paradoxical	effects.	Flumazenil	has	a	
major	advantage	of	benzodiazepines	compared	to	
other	sedative	drugs,	with	a	rapid	antagonistic	effect	
on	sedatives,	easily	reversing	sedation.1,2,10,20,25
Cardiovascular	reactions	are	common	in	surgical	
situations	and	may	be	related	to	the	response	to	the	
activation	of	α	and	β-adrenergic	receptors,	resulting	
in	increased	cardiac	output,	increased	peripheral	
vascular	resistance	and	a	possible	increase	in	blood	
pressure	and	heart	rate,	varying	from	individual	to	
individual.	This	difference	reflects	the	variability	
in	the	adrenal	sympathetic	activation,	which	leads	
to	the	release	of	epinephrine	and	norepinephrine	
during	a	stressful	situation.4
Thus,	oral	sedatives	such	as	benzodiazepines	
should	 be	 used	 to	 reduce	 anxiety,	 pain	 and	
discomfort	of	patients,	improving	the	quality	of	care,	
its	safeness	and	effectiveness.	Although	cognitive	
function	and	physical	coordination	may	be	impaired,	
this	drug	does	not	significantly	affect	airway	reflexes	
and	respiratory	and	cardiovascular	functions	if	
used	rationally;	so,	it	can	be	used	safely	in	patients	
diagnosed	with	heart	disease.3,7,8,13
It	is	important	that	the	professional	conduct	
a	thorough	examination	and	be	able	to	perform	
sedat ion	 and	 know	 the	 pharmacology	 of	
benzodiazepines.	There	should	be	an	incentive	for	
the	use	of	these	drugs	by	the	dentist	because	of	the	
benefits	it	shows.15
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From	this	literature	review,	we	conclude	that:
1. Benzodiazepines	are	indicated	as	oral	sedatives,	
but	are	underused	in	dentistry;
2. They	 are	 indicated	 for	 patients	 with	 anxiety	
when	facing	a	stressful	situation,	which	can	be,	
for	example,	performing	dental	procedures;
3. It	can	be	contraindicated	for	patients	who	have	
severe	 chronic	 respiratory	 insufficiency,	 con-
comitant	use	of	central	nervous	system	depres-
sants,	patients	with	kidney	or	liver	disease,	se-
vere	congestive	heart	failure,	in	pregnancy	and	
during	 lactation.	 Therefore,	 there	 should	 	 be	
precautions	for	its	use	in	these	cases;
4. Advantageously,	 the	 benzodiazepines	 exhibit	
antagonist	 that	 reverses	 its	 effect	 from	 1	 to	 2	
minutes,	flumazenil;
5. It	 is	 important	 that	 the	 dentist	 is	 able	 to	 use	
these	drugs.
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